Evaluating bifurcation coronary interventions using two techniques

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes outcomes from patients who underwent percutaneous coronary intervention (PCI) for bifurcation lesions using either the Culotte technique or the Double Kiss Culotte technique. The research is based on a retrospective review of data collected from two high-volume cardiac departments in Lower Silesia, Poland, between April 2012 and January 2024. The study aims to assess the safety and efficacy of these two stenting techniques in treating acute coronary syndrome. Decisions regarding the PCI procedures were made by a Heart Team based on clinical indications and angiographic features, ensuring informed consent was obtained from all participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Presence of significant changes in the coronary bifurcation requiring the implantation of two coronary stents using the Culotte or DK Culotte technique.

Exclusion Criteria:

* Patients who underwent PCI with coronary stents prior to the index procedure for the bifurcation lesion studied.

Where it's running

• Department of Cardiology, Provincial Specialized Hospital in Legnica,
  Legnica, Lower Silesian Voivodeship, Poland Recruiting
• Department of Cardiology, The Copper Health Centre (MCZ)
  Lubin, Lower Silesian Voivodeship, Poland Recruiting

Study contacts

• Principal investigator: Adrian Włodarczak, Assoc. Prof. — Miedziowe Centrum Zdrowia SA
• Study coordinator: Mateusz Barycki, MD
• Email: mateusz.barycki@gmail.com
• Phone: +48767211446

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients undergoing coronary intervention with orbital atherectomy

  This study is collecting information on patients with hard-to-treat heart blockages who are getting a specific procedure called orbital atherectomy to see how safe and effective it is.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Legnica, Lower Silesian Voivodeship and 1 other locations · NCT06451146

• Registry for patients with refractory angina undergoing Coronary Sinus Reducer implantation

  This study is testing if a new device called the Coronary Sinus Reducer can help people with severe chest pain who haven't found relief from other treatments.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Lubin, Lower Silesian Voivodeship and 1 other locations · NCT06288165

• Registry of patients undergoing coronary interventions with shockwave therapy

  This study is collecting information on patients with hard blockages in their heart arteries who are getting a new shockwave treatment to see how safe and effective it is.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Legnica, Lower Silesian Voivodeship and 1 other locations · NCT05916898

• Switching to Tenofovir Alafenamide for Chronic Hepatitis B Treatment

  This study is testing if switching chronic hepatitis B patients from their current medication to a new one called tenofovir alafenamide can make them happier with their treatment and help them stick to it better.

  Recruiting Taichung Veterans General Hospital · Taichung, Taiwan · NCT05583006

• Comparing two treatments for femoropopliteal artery disease

  This study tests whether a special balloon treatment or a stent works better for people with blocked arteries in their legs.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT05517291

• Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes

  This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.

  Recruiting at 2 sites Phase 4 Getz Pharma · Kabul, Afghanistan and 5 other locations · NCT05164263

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.